
GLP-1 Basics4 min read
CagriSema: Novo Nordisk''s 22.7% Weight Loss Drug Explained
CagriSema is Novo Nordisk's most ambitious new obesity drug. It combines two separate hormone targeting mechanisms in a single weekly injection, and Phase 3 data shows it significa...
A
Anuja Akkar